Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018.

Drug Alcohol Depend

Hennepin Healthcare Research Institute, 701 Park Ave., Suite PP7.700, Minneapolis, MN, 55415, USA; Division of General Internal Medicine, Department of Medicine, Hennepin Healthcare, 716 S 7thSt, Minneapolis, MN, 55415, USA.

Published: September 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Methamphetamine use, with and without opioids, has increased substantially, but little is known about the sociodemographic characteristics, substance use patterns, or health profiles of individuals who use methamphetamine. To design effective public health interventions, health care professionals and policymakers need data describing individuals who are using methamphetamine in the midst of the opioid crisis.

Methods: We used 2015-2018 data from the National Survey on Drug Use and Health and included non-elderly adults aged 18-64 years. We categorized respondents into three groups: use of opioids without methamphetamine use, use of methamphetamine without opioid use, or use of both opioids and methamphetamine. Multiple logistic regression models controlling for sociodemographic factors were used to compare substance use characteristics and measures of individual health between the three groups.

Results: People who used any methamphetamine were more likely to be unstably housed, low-income, and live in rural areas. Use of both opioids and methamphetamine was associated with a 132 % higher prevalence of injection needle use, and a nearly twofold higher prevalence of viral hepatitis compared with opioid use alone. One third of individuals reporting use of both opioids and methamphetamine had a severe mental illness, a 55 % higher prevalence than those using opioids alone.

Conclusions: Individuals who used opioids and methamphetamine had more complex substance use and health profiles than individuals who used opioids alone. These findings suggest public health and harm reduction approaches designed to address opioid use remain important in an era of rising methamphetamine use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147519PMC
http://dx.doi.org/10.1016/j.drugalcdep.2020.108162DOI Listing

Publication Analysis

Top Keywords

opioids methamphetamine
24
health profiles
12
methamphetamine
12
higher prevalence
12
opioids
9
substance patterns
8
health
8
patterns health
8
profiles individuals
8
individuals methamphetamine
8

Similar Publications

Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study.

Am J Psychiatry

September 2025

Michigan Innovations in Addiction Care Through Research and Education (MI-ACRE) Program, Department of Psychiatry, University of Michigan, Ann Arbor.

Objective: While opioid overdose has begun to decrease in recent years, stimulant overdose has continued to increase and has not been adequately addressed. Unlike opioid use disorder, there are no medications approved by the U.S.

View Article and Find Full Text PDF

Global occurrence and distribution of drugs of abuse in rivers: A comprehensive systematic review.

Sci Total Environ

September 2025

Department of Civil and Environmental Engineering, University of Massachusetts Lowell, MA 01854, USA. Electronic address:

The presence of drugs of abuse in freshwater systems is an emerging environmental concern with potential ecological implications. This systematic literature review examines the global occurrence and distribution of ten highly consumed drugs in rivers, including stimulants (cocaine, amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine or MDMA, ketamine) and opioids (codeine, fentanyl, methadone, morphine, tramadol). Using a multi-stage screening process, we identified peer-reviewed articles published between 2012 and 2022, yielding a final dataset covering 225 unique rivers and 865 distinct sampling points across diverse geographic regions.

View Article and Find Full Text PDF

Amid the ongoing global substance use crisis, prenatal health research has increasingly focused on the impact of both licit and illicit substance use on fetal development, and in particular brain development. Magnetic resonance imaging (MRI) has become a critical non-invasive tool for investigating how such exposures influence the developing brain. In this review, we summarize findings from 25 peer-reviewed studies that leverage structural, functional, and diffusion MRI to examine the effects of prenatal exposure to alcohol, opioids, methamphetamines, cocaine, nicotine, or cannabis.

View Article and Find Full Text PDF

Nearly 2 million people had a diagnosis of methamphetamine use disorder (MUD) in 2023 and overdose deaths involving psychostimulants are increasing. Given that there are no currently approved U.S.

View Article and Find Full Text PDF

Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment-resistant depression because of their ability to alter consciousness and afflicted cognitive processes with lasting effects. We aimed to characterise how psychedelics are currently being investigated to treat substance use disorders (SUDs). Additionally, we aimed to summarise the available literature on the dopaminergic consequences of classic psychedelics in the nucleus accumbens (NAc), a foundational component of SUDs, to understand how psychedelics may be therapeutically relevant for SUDs from a neurobiological perspective.

View Article and Find Full Text PDF